Oliver Lagore Vanvalin Investment Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-91
Closed -$19.2K 756
2023
Q4
$19.2K Buy
91
+56
+160% +$11.9K 0.01% 321
2023
Q3
$7.02K Sell
35
-3
-8% -$596 ﹤0.01% 496
2023
Q2
$7.04K Buy
38
+6
+19% +$1.11K ﹤0.01% 527
2023
Q1
$6.13K Buy
+32
New +$5.79K ﹤0.01% 459

Other funds holding CME

Oliver Lagore Vanvalin Investment Group's CME Position: Q1 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of CME Group (CME) in Q1 2024, closing a stake of 91 shares — an estimated $19.2K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in CME in Q1 2023 and held it in 4 quarters. The position peaked at $19.2K in Q4 2023. 1,372 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 91 CME Group shares in Q1 2024, an estimated $19.2K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in CME Group in Q1 2023 and held it in 4 quarters.
  • Oliver Lagore Vanvalin Investment Group's CME Group position peaked at $19.2K in Q4 2023.
  • 1,372 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q1 2024, filed 15 May 2024.